Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: The Ohasama study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 4, 2007, Pages 963-968

  Aono, Yoko ^a   Ohkubo, Takayoshi ^a,b,d   Kikuya, Masahiro ^a   Hara, Azusa ^a   Kondo, Takeo ^b   Obara, Taku ^a,b   Metoki, Hirohito ^a   Inoue, Ryusuke ^a   Asayama, Kei ^b   Shintani, Yoriko ^a   Hashimoto, Junichiro ^a,b   Totsune, Kazuhito ^a   Hoshi, Haruhisa ^c   Satoh, Hiroshi ^a,b   Izumi, Shin Ichi ^b   Imai, Yutaka ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Ohasama Hospital   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Ambulatory blood pressure; Lacunar infarct; Plasma fibrinogen; Silent cerebrovascular lesions; White matter hyperintensity

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRINKING BEHAVIOR; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA VISCOSITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; WHITE MATTER;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 34247275971     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000258947.17570.38     Document Type: Article

References (32)

1. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke. 2003;34:1126-1129.
2. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28: 1932-1939.
3. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
4. Drouet L. Fibrinogen: a treatable risk factor? Cerebrovasc Dis. 1996; 6:2-6.
5. Kannel WB. Influence of fibrinogen on cardiovascular disease. Drugs. 1997;54(Suppl 3):32-40.
6. Fisher M, Meiselman HJ. Hemorheological factors in cerebral ischemia. Stroke. 1991;22:1164-1169.
7. Iwamoto T, Kubo H, Takasaki M. Platelet activation in the cerebral circulation in different subtypes of ischemic stroke and Binswanger's disease. Stroke. 1995;26:52-56.
8. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA. 1987;258: 1183-1186.
9. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501-505.
10. Di Minno G, Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis. 1990;10:1-7.
11. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294:1799-1809.
12. Moons KG, Bots ML, Salonen JT, Elwood PC, Freire de Concalves A, Nikitin Y, Sivenius J, Inzitari D, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE. Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health. 2002;56(Suppl 1):i30-i36.
13. Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study. Eur Heart J. 2003;24:567-576.
14. Sato S, Iso H, Noda H, Kitamura A, Imano H, Kiyama M, Ohira T, Okada T, Yao M, Tanigawa T, Yamagishi K, Nakamura M, Naito Y, Shimamoto T. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women. Stroke. 2006;37:2488-2492.
15. Schmidt R, Fazekas F, Hayn M, Schmidt H, Kapeller P, Roob G, Offenbacher H, Schumacher M, Eber B, Weinrauch V, Kostner GM, Esterbauer H. Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study. J Neurol Sci. 1997;152:15-21.
16. Tsuda Y, Satoh K, Kitadai M, Takahashi T. Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions. J Neurol Sci. 1997;147:49-54.
17. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J, Hofman A. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study. Neurology. 1994;44:1246-1252.
18. Longstreth WT Jr., Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L, for the Cardiovascular Health Study Collaborative Research Group. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The Cardiovascular Health Study Stroke. 1996;27:1274-1282.
19. Sato S, Nakamura M, Iida M, Naito Y, Kitamura A, Okamura T, Nakagawa Y, Imano H, Kiyama M, Iso H, Shimamoto T, Komachi Y. Plasma fibrinogen and coronary heart disease in urban Japanese. Am J Epidemiol. 2000;152:420-423.
20. Lee SC, Park SJ, Ki HK, Gwon HC, Chung CS, Byun HS, Shin KJ, Shin MH, Lee WR. Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension. 2000;36:73-77.
21. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation. 1966;34: 279-298.
22. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension. 1990;16:692-699.
23. Imai Y, Nagai K, Sakuma M, Sakuma H, Nakatsuka H, Satoh H, Minami N, Munakata M, Hashimoto J, Yamagishi T, Watanabe N, Yabe T, Nishiyama A, Abe K. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension. 1993;22:900-912.
24. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Rander H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
25. Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Sekino H, Nihei M, Yoshinaga K. Determination of clinical accuracy and nocturnal blood pressure pattern by new portable device for monitoring indirect ambulatory blood pressure. Am J Hypertens. 1990;3:293-301.
26. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001;6:107-110.
27. Association for the Advancement of Medical Instrumentation. Am national standards for electronic or automated sphygmomanometers. Washington, DC. AAMI Analysis and Review. 1987.
28. Guidelines Subcommittee of the Japanese Society of Hypertension. Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004). Hypertens Res. 2006;29 (Suppl):S1-S105.
29. Wannamethee SG, Lowe GDO, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:1785-1790.
30. Sato S, Iso H, Naito Y, Kiyama M, Kitamura A, Iida M, Shimamoto T, Komachi Y. Plasma fibrinogen and its correlates in urban Japanese men. Int J Epidemiol. 1996;25:521-527.
31. Miura K, Nakagawa H, Ueshima H, Okayama A, Saitoh S, Curb JD, Rodriguez BL, Sakata K, Okuda N, Yoshita K, Stamler J; for the INTERMAP and INTERLIPID Research Groups. Dietary factors related to higher plasma fibrinogen levels of Japanese-americans in Hawaii compared with Japanese in Japan. Arterioscler Thromb Vasc Biol. 2006; 26:1674-1679.
32. Tanne D, Benderly M, Goldbourt U, Boyko V, Brunner D, Graff E, Reicher-Reiss H, Shotan A, Mandelzweig L, Behar S; the Bezafibrate Infarction Prevention Study Group. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the Bezafibrate Infarction Prevention Study. Am J Med. 2001;111:457-463.